Rubric Capital Management LP - Q3 2021 holdings

$3.58 Billion is the total value of Rubric Capital Management LP's 57 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 47.6% .

 Value Shares↓ Weighting
SPY NewSPDR S&P 500 ETF TRput$1,072,850,0002,500,000
+100.0%
30.00%
IWM NewISHARES TRput$765,625,0003,500,000
+100.0%
21.41%
WSC BuyWILLSCOT MOBIL MINI HLDNG CO$98,757,000
+46.8%
3,113,409
+29.0%
2.76%
-34.8%
GSM BuyFERROGLOBE PLC$87,000,000
+610.8%
10,000,000
+400.0%
2.43%
+216.0%
PLYA BuyPLAYA HOTELS & RESORTS NV$86,379,000
+25.6%
10,419,643
+12.5%
2.42%
-44.2%
GLNG BuyGOLAR LNG LTD$73,551,000
+5.6%
5,670,869
+7.9%
2.06%
-53.1%
BGCP BuyBGC PARTNERS INCcl a$63,302,000
-4.6%
12,150,000
+3.8%
1.77%
-57.6%
XPER BuyXPERI HOLDING CORP$59,346,000
+21.3%
3,150,000
+43.2%
1.66%
-46.1%
PARR  PAR PAC HOLDINGS INC$58,164,000
-6.5%
3,700,0000.0%1.63%
-58.5%
ALLY BuyALLY FINL INC$57,498,000
+15.4%
1,126,300
+12.6%
1.61%
-48.7%
TAC  TRANSALTA CORP$54,816,000
+6.0%
5,189,0620.0%1.53%
-52.9%
AHCO NewADAPTHEALTH CORP$53,567,0002,300,000
+100.0%
1.50%
COLL BuyCOLLEGIUM PHARMACEUTICAL INC$51,452,000
-10.1%
2,606,500
+7.7%
1.44%
-60.0%
BuyPACTIV EVERGREEN INC$51,089,000
-9.6%
4,080,586
+8.8%
1.43%
-59.8%
AIR BuyAAR CORP$50,267,000
-0.2%
1,550,000
+19.2%
1.41%
-55.6%
GEF  GREIF INCcl a$46,835,000
+6.7%
725,0000.0%1.31%
-52.6%
CF NewCF INDS HLDGS INC$46,331,000830,000
+100.0%
1.30%
RDUS BuyRADIUS HEALTH INC$45,607,000
+164.0%
3,675,000
+288.0%
1.28%
+17.3%
LORL BuyLORAL SPACE & COM INC$45,161,000
+63.7%
1,050,000
+47.9%
1.26%
-27.2%
GPRE  GREEN PLAINS INC$43,468,000
-2.9%
1,331,3300.0%1.22%
-56.8%
AMYT NewAMRYT PHARMA PLCsponsored ads$39,231,0003,257,005
+100.0%
1.10%
CCO BuyCLEAR CHANNEL OUTDOOR HLDGS$38,907,000
+39.2%
14,356,956
+35.6%
1.09%
-38.1%
ARNC SellARCONIC CORPORATION$37,209,000
-17.8%
1,179,738
-7.2%
1.04%
-63.5%
HMHC SellHOUGHTON MIFFLIN HARCOURT CO$36,638,000
-11.2%
2,728,051
-27.0%
1.02%
-60.5%
ATRS BuyANTARES PHARMA INC$36,400,000
-12.1%
10,000,000
+5.3%
1.02%
-61.0%
FREE BuyWHOLE EARTH BRANDS INC$33,317,000
-14.9%
2,884,554
+6.8%
0.93%
-62.2%
KOP BuyKOPPERS HOLDINGS INC$33,108,000
+2.3%
1,059,120
+5.9%
0.93%
-54.5%
TRIP NewTRIPADVISOR INC$31,201,000921,752
+100.0%
0.87%
HSC BuyHARSCO CORP$28,279,000
+55.7%
1,668,377
+87.5%
0.79%
-30.8%
MREO BuyMEREO BIOPHARMA GROUP PLCads$27,346,000
+52.4%
11,300,000
+99.6%
0.76%
-32.2%
ITOS NewITEOS THERAPEUTICS INC$26,694,000988,683
+100.0%
0.75%
COOP  MR COOPER GROUP INC$26,193,000
+24.5%
636,2210.0%0.73%
-44.7%
CMRX NewCHIMERIX INC$24,760,0004,000,000
+100.0%
0.69%
MTG  MGIC INVT CORP WIS$22,754,000
+10.0%
1,521,0060.0%0.64%
-51.2%
RDN  RADIAN GROUP INC$21,320,000
+2.1%
938,3680.0%0.60%
-54.6%
VINC BuyVINCERX PHARMA INC$21,222,000
+206.1%
1,312,406
+145.9%
0.59%
+36.0%
OMF SellONEMAIN HLDGS INC$20,749,000
-15.4%
375,000
-8.4%
0.58%
-62.4%
KPTI SellKARYOPHARM THERAPEUTICS INC$19,647,000
-55.2%
3,375,758
-20.6%
0.55%
-80.1%
ADV BuyADVANTAGE SOLUTIONS INC$15,912,000
-12.7%
1,839,574
+8.9%
0.44%
-61.2%
MX  MAGNACHIP SEMICONDUCTOR CORP$15,492,000
-25.6%
872,3080.0%0.43%
-66.9%
XPDI NewPOWER & DIGITAL INFRA ACQ CO$15,030,0001,486,620
+100.0%
0.42%
IDCC BuyINTERDIGITAL INC$13,908,000
+441.4%
205,067
+482.9%
0.39%
+140.1%
HY  HYSTER YALE MATLS HANDLING Icl a$11,133,000
-31.1%
221,5140.0%0.31%
-69.4%
NFE NewNEW FORTRESS ENERGY INC$9,875,000355,840
+100.0%
0.28%
KURA BuyKURA ONCOLOGY INC$7,492,000
+55.2%
400,000
+72.8%
0.21%
-30.9%
KDNY BuyCHINOOK THERAPEUTICS INC$7,201,000
+56.5%
564,353
+73.2%
0.20%
-30.7%
SIOX  SIO GENE THERAPIES INC$6,510,000
-20.5%
3,000,0000.0%0.18%
-64.7%
SBBP BuySTRONGBRIDGE BIOPHARMA PLC$6,268,000
-21.7%
3,072,732
+14.0%
0.18%
-65.3%
QSI BuyQUANTUM SI INC$5,608,000
-7.2%
672,385
+36.4%
0.16%
-58.7%
NewJACKSON FINANCIAL INC$5,200,000200,000
+100.0%
0.14%
NAUT BuyNAUTILUS BIOTECHNOLOGY INC$4,590,000
+25.8%
747,607
+107.0%
0.13%
-44.3%
TXMD BuyTHERAPEUTICSMD INC$3,962,000
+19.2%
5,344,302
+91.3%
0.11%
-46.9%
OCUL SellOCULAR THERAPEUTIX INC$3,547,000
-88.4%
354,728
-83.6%
0.10%
-94.9%
RIGL  RIGEL PHARMACEUTICALS INC$2,410,000
-16.3%
663,8560.0%0.07%
-63.0%
REPH  RECRO PHARMA INC$2,218,000
-10.8%
1,076,5870.0%0.06%
-60.5%
VIAO  VIA OPTRONICS AGsponsored ads$1,929,000
-31.7%
251,8550.0%0.05%
-69.7%
KNSA NewKINIKSA PHARMACEUTICALS LTD$1,750,000153,618
+100.0%
0.05%
TXMD ExitTHERAPEUTICSMD INCcall$0-15,400
-100.0%
-0.00%
XL ExitXL FLEET CORPput$0-41,500
-100.0%
-0.02%
GOEV ExitCANOO INCput$0-45,500
-100.0%
-0.03%
APPH ExitAPPHARVEST INCput$0-43,000
-100.0%
-0.04%
RIDE ExitLORDSTOWN MOTORS CORPput$0-64,000
-100.0%
-0.04%
MVIS ExitMICROVISION INC DEL$0-49,595
-100.0%
-0.05%
FUV ExitARCIMOTO INCput$0-71,500
-100.0%
-0.08%
SOFI ExitSOFI TECHNOLOGIES INCput$0-192,500
-100.0%
-0.23%
MARA ExitMARATHON DIGITAL HOLDINGS IN$0-159,134
-100.0%
-0.31%
UEPS ExitNET 1 UEPS TECHNOLOGIES INC$0-1,151,941
-100.0%
-0.34%
MORF ExitMORPHIC HLDG INC$0-304,410
-100.0%
-1.10%
SC ExitSANTANDER CONSUMER USA HLDGS$0-547,946
-100.0%
-1.25%
FBP ExitFIRST BANCORP P R$0-1,973,369
-100.0%
-1.48%
BPOP ExitPOPULAR INC$0-363,954
-100.0%
-1.72%
TTMI ExitTTM TECHNOLOGIES INC$0-2,194,126
-100.0%
-1.98%
TROX ExitTRONOX HOLDINGS PLC$0-1,441,466
-100.0%
-2.03%
CHMA ExitCHIASMA INC$0-7,250,000
-100.0%
-2.16%
KRA ExitKRATON CORP$0-1,650,000
-100.0%
-3.35%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAGNACHIP SEMICONDUCTOR CORP28Q3 20234.7%
BGC PARTNERS INC20Q2 20234.6%
MR COOPER GROUP INC20Q3 20235.9%
PAR PACIFIC HOLDINGS INC18Q3 20233.9%
RADIUS HEALTH INC16Q2 20224.3%
CLEAR CHANNEL OUTDOOR HLDGS16Q3 20232.6%
HERON THERAPEUTICS INC15Q3 20239.0%
COLLEGIUM PHARMACEUTICAL INC15Q3 20233.9%
AAR CORP14Q3 20233.2%
GREEN PLAINS INC14Q3 20224.1%

View Rubric Capital Management LP's complete holdings history.

Latest significant ownerships (13-D/G)
Rubric Capital Management LP Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
HERON THERAPEUTICS, INC. /DE/July 25, 202326,713,50319.0%
Amryt Pharma plcFebruary 10, 202318,000,0005.6%
BGC Partners, Inc.February 10, 202318,250,0005.6%
EverQuote, Inc.February 10, 20231,246,6224.8%
Ferroglobe PLCFebruary 10, 20233,232,7621.7%
Sio Gene Therapies Inc.February 10, 20237,000,0009.5%
Vincerx Pharma, Inc.February 10, 2023386,7191.8%
Whole Earth Brands, Inc.February 10, 2023998,3632.4%
Radius Health, Inc.June 16, 20226,959,30514.6%
ANTARES PHARMA, INC.February 14, 202210,800,0006.4%

View Rubric Capital Management LP's complete significant-ownership history.

Latest filings
TypeFiled
DEFC14A2024-04-17
DFAN14A2024-04-17
SC 13D/A2024-04-16
PRRN14A2024-04-02
PRRN14A2024-03-26
DFAN14A2024-03-11
PREC14A2024-03-08
SC 13D/A2024-02-21
SC 13D/A2024-02-14
13F-HR2024-02-13

View Rubric Capital Management LP's complete filings history.

Compare quarters

Export Rubric Capital Management LP's holdings